U.S. Infrastructure Stock News

NasdaqGM:SITM
NasdaqGM:SITMSemiconductor

Is SiTime (SITM) Undervalued As Analysts Raise Earnings Estimates?

Recent analyst coverage has put fresh attention on SiTime (SITM), as Wall Street firms describe the timing chip specialist as a technology disruptor and highlight raised earnings estimates that reflect more constructive sentiment. See our latest analysis for SiTime. SiTime’s share price has been volatile in recent months, with a 7 day share price return that declined 13.64% and a 90 day share price return that declined 15.61%. However, the year to date share price return of 66.19% and 1 year...
NasdaqGS:INTA
NasdaqGS:INTASoftware

Is Intapp (INTA) Expensive Following Its Celeste AI Launch?

Intapp (INTA) stock has been in focus after the company introduced Compliance with Celeste and Time with Celeste, bringing agentic AI into client intake, risk checks, and time capture for professional services firms. See our latest analysis for Intapp. Against this product launch backdrop, Intapp’s share price has climbed 58.61% over the past 30 days and 102.70% over 90 days, although the year to date share price return is down 5.74% and the 1 year total shareholder return is down 3.43%. This...
NYSE:TAL
NYSE:TALConsumer Services

TAL Education Group (TAL) Stock Looks Cheap Relative To Earnings Outlook

TAL Education Group stock has delivered a strong 135.8% gain over the past 5 years, yet the current valuation checks still suggest the shares screen as undervalued on several fronts. Over the past 5 years, TAL Education Group has returned 135.8%, which puts recent short term moves into context for longer term holders. Recent coverage highlighting upgraded earnings expectations and a low PEG ratio can support optimism on growth, while any disappointment in how those expectations translate...
NYSE:EROC
NYSE:EROCElectrical

Nvidia Stock Read Through For AI Data Center Infrastructure Picks

AI data centers are pulling huge amounts of power, cooling and hardware into the spotlight just as Nvidia’s Q2 earnings, rising Treasury yields and the Jackson Hole meeting focus attention on how long the AI buildout might run. That mix of excitement and rate anxiety is reshaping expectations. In this article, you will see three stocks that sit close to this theme and how the same news could affect each one. The three stocks highlighted next are just a sample of what the AI data center...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Henry Schein (HSIC) And The Digital Growth Narrative Following A Valuation Recheck

Henry Schein (HSIC) is back in focus after recent share price moves, with the stock last closing at US$88.50. Investors are assessing how the current valuation lines up with the company’s fundamentals and recent performance. See our latest analysis for Henry Schein. Recent moves have come after a solid run, with Henry Schein’s 90 day share price return of 19.26% and year to date share price return of 15.20%, alongside a 1 year total shareholder return of 27.16%. If you are assessing Henry...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

Fermi (FRMI) Is Down 7.5% After New CEO, Wider Losses And 2.6 GW Power Deal – Has The Bull Case Changed?

Fermi Inc. recently appointed industry veteran Lee McIntire as CEO and reported a wider second-quarter net loss of US$25.81 million and six-month net loss of US$214.50 million, while also securing a framework agreement with Hillcore Energy Capital to develop a roughly 2.6 GW power complex at its Project Matador campus in Texas. The Hillcore Build-Own-Operate-Transfer arrangement gives Fermi access to gigawatts of behind-the-meter power capacity with no upfront capital outlay, potentially...
NasdaqCM:SLS
NasdaqCM:SLSBiotechs

Are SELLAS Life Sciences (SLS) Loss Trends Masking a Shifting Cancer Vaccine Investment Narrative?

SELLAS Life Sciences Group, Inc. reported second-quarter 2026 results, with net loss rising to US$9.61 million from US$6.60 million a year earlier, while basic loss per share from continuing operations narrowed to US$0.05 from US$0.07. For the first half of 2026, the company’s net loss increased to US$18.01 million from US$12.41 million, yet basic loss per share improved to US$0.10 from US$0.13, as investor attention was also drawn to renewed interest in immune-based cancer therapies...
NYSE:DELL
NYSE:DELLTech

Is Dell (DELL) Quietly Turning Esports Partnerships Into a Differentiated AI Hardware Strategy?

Earlier this month, Team Liquid announced a new five-year extension of its collaboration with Dell Technologies’ Alienware brand, carrying the esports partnership through 2031 and deepening cooperation across hardware, product development, content, events and training facilities on three continents. This renewal underscores how Dell is using long-term esports alliances not just for marketing, but as a real-world R&D lab to refine high-performance gaming products and brand credibility among...
NYSE:TSN
NYSE:TSNFood

Will Landmark Broilers Antitrust Settlement and Compliance Overhaul Change Tyson Foods' (TSN) Narrative

In August 2026, a consumer class of hundreds of millions moved toward final court approval of a sweeping antitrust settlement with Agri Stats in the long-running Broilers litigation, which alleges major chicken producers including Tyson Foods colluded to fix U.S. chicken prices and destroy livestock to constrain supply. The settlement not only returns hundreds of millions of dollars to consumers but also imposes extensive data-sharing and compliance reforms that could reshape pricing...
NasdaqCM:NKTR
NasdaqCM:NKTRPharmaceuticals

How Investors Are Reacting To Nektar Therapeutics (NKTR) Q2 Loss, ESOP Shelf Registration And Financing Flexibility

Nektar Therapeutics recently reported second-quarter 2026 results showing revenue of US$10.13 million and a net loss of US$40.62 million, while also filing a US$219.06 million shelf registration covering 3,000,000 common shares for an ESOP-related offering. The combination of a reduced loss per share from continuing operations and new financing flexibility through the shelf registration reshapes how investors may view Nektar’s financial profile and capital options. Next, we will examine how...
NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

Cintas (CTAS) Stock Looks Fully Valued After Its 118% Five Year Run

Cintas stock has delivered a strong 118.1% return over the past five years, yet current checks suggest it no longer looks like a clear bargain, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a price that is roughly in line with where the shares trade and earnings multiples screening as expensive. That mix leaves investors weighing a solid long term share price record against signals that the current valuation may already reflect a lot of good news. Over the last 5...
NYSE:BCC
NYSE:BCCTrade Distributors

Boise Cascade (BCC), Why Is The Stock Back In Focus?

Boise Cascade (BCC) has been drawing attention after recent share price moves, with the stock last closing at US$82.47. Investors are weighing this level against the company’s fundamentals and recent business performance. See our latest analysis for Boise Cascade. Recent price action shows Boise Cascade with a 1 month share price return of 6.1% and a 3 month share price return of 22.8%, while the 1 year total shareholder return declined 8.6%. This suggests that shorter term momentum has...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

Advanced Micro Devices (AMD) Stock Looks Cheap On Cash Flow Yet Pricey On Earnings

Advanced Micro Devices stock has delivered a very strong run over the past few years, yet the latest valuation checks send mixed signals. The Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside, while traditional market multiples suggest the shares are already priced richly. Advanced Micro Devices has returned 362.8% over the past 3 years, which puts extra focus on whether recent gains already reflect investors' expectations for its role in AI data center...
NYSE:KKR
NYSE:KKRCapital Markets

Why KKR (KKR) Is Back In The Spotlight

KKR (KKR) is back in focus after NVIDIA announced a planned alliance with the firm and several global asset managers to create large compute financing platforms that support AI infrastructure across NVIDIA’s customer base. See our latest analysis for KKR. The NVIDIA alliance lands as KKR’s share price trades at US$108.48, with a 30 day share price return of 13.56% and a 90 day share price return of 15.36%. However, the year to date share price return has declined 15.84% and the 1 year total...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

How SoFi’s Crypto Rally and Record Member Growth Could Reshape SoFi Technologies (SOFI) Investors

Earlier this week, SoFi Technologies benefited from a broad rally in crypto-exposed fintechs after Bitcoin’s breakout, while also reporting a record 1.1 million new members added in Q2 2026 alongside a 48% increase in sales and marketing spend. This combination of stronger crypto-related sentiment and aggressive user acquisition efforts has sharpened investor focus on how SoFi’s newer products and faster member growth could influence its long-term business mix and profitability profile. With...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Nasdaq Stock Leads Ex Hong Kong Financial Centres Investors Are Watching

As Hong Kong’s tightening political climate puts its status as a global financial hub under scrutiny, attention is drifting toward other financial centres that may gain from any shift in listings and trading activity. That creates both risk and potential opportunity for investors watching exchange and clearing stocks. This article walks through three stocks exposed to these headlines and explains how the same story can play out in different ways across markets. The stocks featured below are a...
NYSE:MO
NYSE:MOTobacco

Resilient Earnings And Higher 2026 Outlook Might Change The Case For Investing In Altria (MO)

Altria Group’s recent second-quarter earnings report showed year-over-year adjusted profit growth and a higher low end of its 2026 earnings outlook, even as U.S. cigarette volumes continued to decline. The results underscored how pricing power, improved smokeable margins, and cigarette import/export benefits are helping offset weaker oral tobacco performance and higher capital spending. We’ll now explore how this combination of earnings resilience and raised guidance may influence Altria’s...
NYSE:VPG
NYSE:VPGElectronic

Cleveland Cliffs Investment Puts These AI Automation Stocks On Watch

Cleveland-Cliffs just committed US$1b to upgrade its Middletown Works plant with AI-enabled process controls, which puts a fresh spotlight on companies that help factories run smarter and cheaper. That kind of spending can ripple across suppliers and rivals, and investors who ignore it risk missing where capital is quietly flowing. This article walks through three stocks exposed to this news and how each might fit into your watchlist. The stocks below are just a starting sample of industrial...
NYSE:HD
NYSE:HDSpecialty Retail

Home Depot (HD) CEO Takes Medical Leave As Interim Leaders Step In

Home Depot (NYSE:HD) CEO Edward P. Decker has taken a temporary medical leave of absence, with the board outlining an interim leadership plan. Long-serving executives Ann-Marie Campbell and Richard V. McPhail have been appointed to lead oversight duties on an interim basis to support continuity. The company has framed the changes as temporary, with existing senior leadership stepping into expanded roles during Decker's absence. This kind of leadership change is not unique to Home Depot, so...
NYSE:BNT
NYSE:BNTInsurance

Higher Treasury Yields Are Reshaping U.S. Life Insurance Stocks

Long term US Treasury yields are back in the spotlight, with 30 year bonds near 5.2% and 10 year notes near 4.7%. That reshapes how money is priced across the economy and can punish some stocks while opening the door for others whose business models lean on higher long dated returns. This article walks through three U.S. life insurance and annuity stocks closely exposed to this rate shock and discusses why they may warrant closer examination now. The three stocks in this article are just a...
NYSE:TWLO
NYSE:TWLOIT

Twilio (TWLO) Stock May Trade At A Premium As Outlook Rises

After a strong three year run where Twilio stock has delivered a 279.5% return, the shares now sit in an awkward spot. The intrinsic value estimate from a Discounted Cash Flow (DCF) model points to a price that is roughly in line with the market, while the market multiple checks lean toward Twilio looking expensive. Over the past three years Twilio has returned 279.5%, which sets a high bar for any further gains to be justified by fundamentals. Stronger expectations for revenue growth and...
NYSE:DAO
NYSE:DAOConsumer Services

Youdao (DAO) Stock Rallies On Margin Surge As Growth Questions Persist

Youdao went into this earnings print priced for perfection, trading on a P/E of 92.5x after a 30 day run of about 24%. The stock popped another 9% to $18.37 as investors reacted to one headline number. Q2 operating profit reached ¥111.5m, close to four times the level a year earlier, and net income attributable to ordinary shareholders came in at ¥73.8m. The story today is not top line growth; the story is margin power and the question of how long this new profitability gear can hold. Is...
NYSE:ADNT
NYSE:ADNTAuto Components

Will Automation Spending and Plant Consolidation Shift Adient's (ADNT) Efficiency and Risk Narrative?

Earlier in fiscal 2026, Adient executives stated they expected to finish the year in line with commitments and enter fiscal 2027 with continued revenue growth, better business performance, and margin expansion supported by Americas onshoring, China operations, and higher automation spending. Management also outlined plans to consolidate four Americas plants and fund both restructuring and automation-driven cost reductions through asset sale proceeds, signaling an intensified focus on capital...
NYSE:A
NYSE:ALife Sciences

Why Agilent Technologies (A) Is Up 7.0% After Q2 Beat And Higher 2026 Guidance - And What's Next

In Q2 2026, Agilent Technologies reported results that exceeded expectations and raised its fiscal 2026 guidance, prompting analysts to reiterate a “Moderate Buy” consensus as of August 2026. This combination of stronger-than-anticipated performance and higher guidance has reinforced confidence in Agilent’s ability to execute on its life sciences and diagnostics-focused business model. Next, we’ll examine how Agilent’s upgraded 2026 guidance affects its investment narrative, particularly...